175 related articles for article (PubMed ID: 37761360)
21. Molecular characterization of colorectal cancer using whole-exome sequencing in a Taiwanese population.
Chang YS; Lee CC; Ke TW; Chang CM; Chao DS; Huang HY; Chang JG
Cancer Med; 2019 Jul; 8(8):3738-3747. PubMed ID: 31127692
[TBL] [Abstract][Full Text] [Related]
22. Mutation Spectrum of Cancer-Associated Genes in Patients With Early Onset of Colorectal Cancer.
Zhunussova G; Afonin G; Abdikerim S; Jumanov A; Perfilyeva A; Kaidarova D; Djansugurova L
Front Oncol; 2019; 9():673. PubMed ID: 31428572
[No Abstract] [Full Text] [Related]
23. Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel.
AlHarbi M; Mobark NA; AlJabarat WAR; ElBardis H; AlSolme E; Hamdan AB; AlFakeeh AH; AlMushawah F; AlHarthi F; AlSharm AA; Balbaid AAO; AlJohani N; Zhou AY; Robinson HA; Alqahtani SA; Abedalthagafi M
Oncotarget; 2023 Jun; 14():580-594. PubMed ID: 37306523
[TBL] [Abstract][Full Text] [Related]
24. Molecular Characterization of Somatic Alterations in Dukes' B and C Colorectal Cancers by Targeted Sequencing.
Abdul SN; Ab Mutalib NS; Sean KS; Syafruddin SE; Ishak M; Sagap I; Mazlan L; Rose IM; Abu N; Mokhtar NM; Jamal R
Front Pharmacol; 2017; 8():465. PubMed ID: 28769798
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
[TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of a 10-gene panel for colorectal cancer in Huizhou, Guangdong Province of China.
Li J; Sun A; Zhong G; He Y; Xiong H; Yuan X
J Int Med Res; 2021 Nov; 49(11):3000605211061040. PubMed ID: 34851763
[TBL] [Abstract][Full Text] [Related]
27. Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas.
Wang J; Li R; He Y; Yi Y; Wu H; Liang Z
Mod Pathol; 2020 Dec; 33(12):2591-2601. PubMed ID: 32620917
[TBL] [Abstract][Full Text] [Related]
28. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
Kim H; Kim BH; Lee D; Shin E
Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
[TBL] [Abstract][Full Text] [Related]
29. Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS.
Cannon TL; Randall JN; Sokol ES; Alexander SM; Wadlow RC; Winer AA; Barnett DM; Rayes DL; Nimeiri HS; McGregor KA
Cancer Treat Res Commun; 2022; 32():100569. PubMed ID: 35567913
[TBL] [Abstract][Full Text] [Related]
30. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
[TBL] [Abstract][Full Text] [Related]
31. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
[TBL] [Abstract][Full Text] [Related]
32. Identification of Genomic Alterations in Thai Patients With Colorectal Cancer Using Next-Generation Sequencing-Based Multigene Cancer Panel.
Jinda W; Moungthard H; Limwongse C; Pithukpakorn M; Saelee P; Pokkasup N; Khunpukdee S; Sukthaworn S; Jumpasri J
Cureus; 2023 May; 15(5):e39067. PubMed ID: 37323311
[TBL] [Abstract][Full Text] [Related]
33. Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights.
Dienstmann R; Elez E; Argiles G; Matos I; Sanz-Garcia E; Ortiz C; Macarulla T; Capdevila J; Alsina M; Sauri T; Verdaguer H; Vilaro M; Ruiz-Pace F; Viaplana C; Garcia A; Landolfi S; Palmer HG; Nuciforo P; Rodon J; Vivancos A; Tabernero J
Mol Oncol; 2017 Sep; 11(9):1263-1272. PubMed ID: 28618197
[TBL] [Abstract][Full Text] [Related]
34. Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy.
Lin PC; Yeh YM; Chan RH; Lin BW; Chen PC; Pan CC; Shen MR
BMC Cancer; 2021 Mar; 21(1):217. PubMed ID: 33653301
[TBL] [Abstract][Full Text] [Related]
35. Detection of a novel panel of 24 genes with high frequencies of mutation in gastric cancer based on next-generation sequencing.
Zeng HH; Yang Z; Qiu YB; Bashir S; Li Y; Xu M
World J Clin Cases; 2022 May; 10(15):4761-4775. PubMed ID: 35801059
[TBL] [Abstract][Full Text] [Related]
36. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
[TBL] [Abstract][Full Text] [Related]
37. Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer.
Huang W; Li W; Xu N; Li H; Zhang Z; Zhang X; He T; Yao J; Xu M; He Q; Guo L; Zhang S
Cancer Med; 2023 May; 12(9):10187-10198. PubMed ID: 37096801
[TBL] [Abstract][Full Text] [Related]
38. A prognostic predictive model constituted with gene mutations of
Zheng L; Zhan Y; Lu J; Hu J; Kong D
Ann Transl Med; 2021 Apr; 9(8):680. PubMed ID: 33987378
[TBL] [Abstract][Full Text] [Related]
39. Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer.
Shanmugam V; Ramanathan RK; Lavender NA; Sinari S; Chadha M; Liang WS; Kurdoglu A; Izatt T; Christoforides A; Benson H; Phillips L; Baker A; Murray C; Hostetter G; Von Hoff DD; Craig DW; Carpten JD
BMC Med Genomics; 2014 Jun; 7():36. PubMed ID: 24943349
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of pathogenic variants in actionable genes in advanced ovarian cancer: a next-generation sequencing analysis of a nationwide registry study.
Kang S; Yu YL; Cho SY; Park SY
Eur J Cancer; 2020 Dec; 141():185-192. PubMed ID: 33166861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
